P3671Myocardial regeneration strategy using Wharton's jelly multipotent stem cells as an "unlimited" therapeutic agent: 3-year outcomes in a pilot cohort of circulate-acute myocardial infarction trial. (28th August 2018) - Kwiecien, E; Drabik, L; Mazurek, A; Urbanczyk, M; Szot, W; Kostkiewicz, M; Banys, R P; Kozynacka, A; Plazak, W; Olszowska, M; Jarocha, D; Prokop-Staszecka, A; et al.